Literature DB >> 20818726

The neurologic manifestations of mitochondrial disease.

Sumit Parikh1.   

Abstract

The nervous system contains some of the body's most metabolically demanding cells that are highly dependent on ATP produced via mitochondrial oxidative phosphorylation. Thus, the neurological system is consistently involved in patients with mitochondrial disease. Symptoms differ depending on the part of the nervous system affected. Although almost any neurological symptom can be due to mitochondrial disease, there are select symptoms that are more suggestive of a mitochondrial problem. Certain symptoms that have become sine qua non with underlying mitochondrial cytopathies can serve as diagnostic "red-flags." Here, the typical and atypical presentations of mitochondrial disease in the nervous system are reviewed, focusing on "red flag" neurological symptoms as well as associated symptoms that can occur in, but are not specific to, mitochondrial disease. The multitudes of mitochondrial syndromes are not reviewed in-depth, though a select few are discussed in some detail. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20818726     DOI: 10.1002/ddrr.110

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  10 in total

1.  Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy.

Authors:  Konark Mukherjee; Helen R Clark; Vrushali Chavan; Emily K Benson; Grahame J Kidd; Sarika Srivastava
Journal:  J Vis Exp       Date:  2016-07-09       Impact factor: 1.355

Review 2.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 3.  Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics.

Authors:  Tamara E Lacourt; Cobi J Heijnen
Journal:  Curr Breast Cancer Rep       Date:  2017-04-22

4.  A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008-2015.

Authors:  Bruce Cohen; Cristy Balcells; Brian Hotchkiss; Kavita Aggarwal; Amel Karaa
Journal:  Orphanet J Rare Dis       Date:  2018-11-22       Impact factor: 4.123

Review 5.  Maxwell's demon at work: Mitochondria, the organelles that convert information into energy?

Authors:  Ya Wen
Journal:  Chronic Dis Transl Med       Date:  2018-06-11

Review 6.  Fission Impossible (?)-New Insights into Disorders of Peroxisome Dynamics.

Authors:  Ruth E Carmichael; Markus Islinger; Michael Schrader
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

7.  Cognitive functioning and mental health in children with a primary mitochondrial disease.

Authors:  Kim F E van de Loo; José A E Custers; Lonneke de Boer; Marloes van Lieshout; Maaike C de Vries; Mirian C H Janssen; Christianne M Verhaak
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

Review 8.  Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders).

Authors:  Serena Asslih; Odeya Damri; Galila Agam
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 9.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

Review 10.  An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.

Authors:  Ankit Das; Niraja Ranadive; Manas Kinra; Madhavan Nampoothiri; Devinder Arora; Jayesh Mudgal
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.